Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy

Matthias Volkmar Kopp*, Eckard Hamelmann, Meike Bendiks, Stefan Zielen, Wolfgang Kamin, Karl Christian Bergmann, Christian Klein, Ulrich Wahn

*Corresponding author for this work
33 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences